Project Grant R21AG083727

Award Date 8/15/24
Completion Date 7/31/26
Dollars Obligated $443K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Buffalo, NY 14214, USA
Similar Awards
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), provides $241,500.00 to The Research Foundation For The State University Of New York to identify diffusible small molecules that regulate the replication of the oral bacteria Porphyromonas gingivalis. The research aims to elucidate the mechanisms by which this late-colonizing bacterium overcomes growth limitations and...
This $550,627 Project Grant was awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) to the Augusta University Research Institute, Inc. (doing business as Georgia Health Sciences) to conduct research on the role of oral microbially induced exosomes in the pathogenesis of Alzheimer's disease and related dementias (ADRD). The research aims to investigate how exosomes released from gingival tissues during periodontal disease infection may cross the blood-brain barrier and...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $226,500 Project Grant (CFDA 93.121 - Oral Diseases and Disorders Research) to the Medical University of South Carolina to study the role of CD38 signaling in aging-associated immune responses induced by oral pathogens. The goal is to define how oral pathogens affect aging-associated immune responses and whether inhibition of CD38 can attenuate inflammatory bone loss and alleviate aging-associated immune responses...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $1,853,477 to the Research Foundation for Mental Hygiene, Inc. (RFMH) at the Nathan S. Kline Institute to conduct research on hyperexcitability and interictal spike activity in Alzheimer's disease. The research aims to investigate the origins and mechanisms of these neural phenomena, as well as evaluate whether selectively inhibiting them can improve cognition and reduce...
This federal Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to investigate functional amyloid formation in the oral bacterium Streptococcus mutans. The total funding amount is $505,530 and the award period runs from September 16, 2024 to September 15, 2025. The key research objectives include: (1) exploring the relationships between S. mutans amyloid-forming...
This $794,341 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) is supporting research to investigate the role of cellular senescence and blood-brain barrier dysfunction in Alzheimer's disease progression. The research project, led by the University of Illinois, aims to elucidate how viral and bacterial pathogens can initiate blood-brain barrier dysfunction and cellular senescence, which in turn promote neuroinflammation and Alzheimer's disease...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to New York University will provide $819,054 to conduct a multifaceted study examining the link between oral health and different subtypes of dementia, including Alzheimer's disease and vascular dementia. The research will analyze data from large population-based datasets to investigate the biological pathways and social determinants underlying this relationship. A sub-award of $263,002 will go...
This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will provide $401,500.00 to Louisiana State University Health Sciences Center-Shreveport to investigate fundamental aspects of the innate immune response to SARS-CoV-2 within the salivary gland. The project aims to explore how antigen presentation mechanisms may shape or reflect local immune activity in this tissue, which will...
The Research Foundation for the State University of New York (RF-SUNY) has been awarded a $300,000 "Trans-NIH Research Support" Project Grant (CFDA 93.310) from the National Institutes of Health (NIH) Office of the Director. The purpose of this 1-year award, effective September 1, 2023, is to investigate the role of cellular senescence and associated inflammatory signaling (the senescence-associated secretory phenotype or SASP) in promoting salivary gland dysfunction in Sjogren's...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $107,948 to the University of Rochester to characterize a regulatory signaling axis that promotes astrocyte-driven central nervous system pathology in Parkinson's disease (PD). The project aims to evaluate the role of the sigma-1 receptor (SIGMAR1) on astrocyte and astrocyte-microglia pro-inflammatory responses induced by Parkinson's disease-associated stimuli, as well as the effect of SIGMAR1...

This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $442,750 to The Research Foundation For The State University Of New York (RF SUNY) to investigate the role of oral spirochetes in promoting neuroinflammation and dysfunction.

The key objectives are to: 1) Characterize the ability of oral spirochetes to induce blood-brain barrier dysfunction, and 2) Assess the capacity of oral spirochetes to drive an inflammatory response in glial cells of the neurovascular unit. This research aims to elucidate the underlying mechanisms linking oral microbiome dysbiosis, neuroinflammation, and neurodegenerative disorders. The award period runs from Aug 15, 2024 to Jul 31, 2026.

Generated 7/1/25, 2:42 AM